IMARC's 2009 warning letter "report card" is in! After reviewing warning letters issued to investigators and sponsor-investigators in 2011 through the FDA's Bioresearch Monitoring Inspection Program, IMARC’s clinical monitoring team has assembled the following "TOP 10" list.
Complete the form to read more about 2009 Top FDA Warning Letter Findings.
